Detalhe da pesquisa
1.
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma.
Int J Mol Sci
; 23(23)2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499093
2.
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.
Br J Haematol
; 195(1): 95-107, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500493
3.
The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab.
Neurol Sci
; 42(7): 2847-2853, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33201361
4.
Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant.
Neoplasma
; 68(3): 519-527, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618517
5.
Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients.
Eur J Haematol
; 104(3): 190-197, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31763708
6.
Heparin-induced thrombocytopenia: a case report and literature overview.
Vnitr Lek
; 66(4): 242-248, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32972188
7.
Systemic inflammatory response with high CRP values as the dominant symptom of multiple myeloma.
Vnitr Lek
; 65(1): 37-44, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30823836
8.
Activity of aldehyde dehydrogenase in B-cell and plasma cell subsets of monoclonal gammopathy patients and healthy donors.
Eur J Haematol
; 98(1): 19-25, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27199264
9.
Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.
Eur J Haematol
; 99(6): 469-478, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886236
10.
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.
Eur J Haematol
; 99(1): 80-90, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28384387
11.
Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network.
Haematologica
; 106(5): 1496-1499, 2020 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054135
12.
Plasma cell leukemia: from biology to treatment.
Eur J Haematol
; 95(1): 16-26, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25778450
13.
Nestin expression throughout multistep pathogenesis of multiple myeloma.
Br J Haematol
; 164(5): 701-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24329895
14.
JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia.
Clin Hemorheol Microcirc
; 84(4): 359-368, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334581
15.
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
J Clin Oncol
; 41(7): 1383-1392, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315921
16.
The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms.
In Vivo
; 35(6): 3345-3353, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697168
17.
Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma.
J Clin Med
; 10(16)2021 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34442012
18.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.
Blood Cancer J
; 11(6): 106, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083504
19.
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.
Leukemia
; 36(1): 288-291, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247197
20.
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.
Blood Adv
; 6(2): 368-372, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500459